Cargando…

Improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients

AIMS: Few studies have examined how improved metabolic control might influence vibration perception thresholds (VPTs). The aim of this study was to evaluate if improved HbA(1c) can influence vibration thresholds in adults with type 1 diabetes (T1DM). METHODS: VPTs were investigated at six frequencie...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahlin, Lars B., Elgzyri, Targ, Löndahl, Magnus, Ekman, Linnéa, Lindholm, Eero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093360/
https://www.ncbi.nlm.nih.gov/pubmed/31705298
http://dx.doi.org/10.1007/s00592-019-01450-2
_version_ 1783510267199488000
author Dahlin, Lars B.
Elgzyri, Targ
Löndahl, Magnus
Ekman, Linnéa
Lindholm, Eero
author_facet Dahlin, Lars B.
Elgzyri, Targ
Löndahl, Magnus
Ekman, Linnéa
Lindholm, Eero
author_sort Dahlin, Lars B.
collection PubMed
description AIMS: Few studies have examined how improved metabolic control might influence vibration perception thresholds (VPTs). The aim of this study was to evaluate if improved HbA(1c) can influence vibration thresholds in adults with type 1 diabetes (T1DM). METHODS: VPTs were investigated at six frequencies (4–125 Hz) using VibroSense Meter in the sole of the foot at two occasions in 159 T1DM patients, at the heads of the first and fifth metatarsal bones, i.e. MTH1 and MTH5, respectively. The participants were divided into three groups: group A: HbA(1c) improved by more than 1 mmol/mol (n = 95), group B: HbA(1c) deteriorated by more than 1 mmol/mol (n = 48) and group C: HbA(1c) unchanged (± 1 mmol/mol) (n = 16) compared to baseline. RESULTS: In group A, the mean z-score, reflecting the combined effect of all VPTs, improved being lower at the follow-up than at the baseline [0.2 (− 0.3 to 1.2) vs. −0.1 (− 0.7 to 0.8), p = 0.00002]. VPTs improved at 4 and 64 Hz at both MTH1 (metatarsal head 1) and MTH5. The VPTs at 125 Hz frequency improved at MTH5, but not at MTH1. No significant differences were seen in group B or group C. CONCLUSIONS: Lower HbA(1c) and lower VPTs in T1DM patients were associated with improved VPT, suggesting a reversible effect on nerve function by improved metabolic control.
format Online
Article
Text
id pubmed-7093360
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-70933602020-03-26 Improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients Dahlin, Lars B. Elgzyri, Targ Löndahl, Magnus Ekman, Linnéa Lindholm, Eero Acta Diabetol Original Article AIMS: Few studies have examined how improved metabolic control might influence vibration perception thresholds (VPTs). The aim of this study was to evaluate if improved HbA(1c) can influence vibration thresholds in adults with type 1 diabetes (T1DM). METHODS: VPTs were investigated at six frequencies (4–125 Hz) using VibroSense Meter in the sole of the foot at two occasions in 159 T1DM patients, at the heads of the first and fifth metatarsal bones, i.e. MTH1 and MTH5, respectively. The participants were divided into three groups: group A: HbA(1c) improved by more than 1 mmol/mol (n = 95), group B: HbA(1c) deteriorated by more than 1 mmol/mol (n = 48) and group C: HbA(1c) unchanged (± 1 mmol/mol) (n = 16) compared to baseline. RESULTS: In group A, the mean z-score, reflecting the combined effect of all VPTs, improved being lower at the follow-up than at the baseline [0.2 (− 0.3 to 1.2) vs. −0.1 (− 0.7 to 0.8), p = 0.00002]. VPTs improved at 4 and 64 Hz at both MTH1 (metatarsal head 1) and MTH5. The VPTs at 125 Hz frequency improved at MTH5, but not at MTH1. No significant differences were seen in group B or group C. CONCLUSIONS: Lower HbA(1c) and lower VPTs in T1DM patients were associated with improved VPT, suggesting a reversible effect on nerve function by improved metabolic control. Springer Milan 2019-11-08 2020 /pmc/articles/PMC7093360/ /pubmed/31705298 http://dx.doi.org/10.1007/s00592-019-01450-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Dahlin, Lars B.
Elgzyri, Targ
Löndahl, Magnus
Ekman, Linnéa
Lindholm, Eero
Improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients
title Improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients
title_full Improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients
title_fullStr Improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients
title_full_unstemmed Improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients
title_short Improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients
title_sort improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093360/
https://www.ncbi.nlm.nih.gov/pubmed/31705298
http://dx.doi.org/10.1007/s00592-019-01450-2
work_keys_str_mv AT dahlinlarsb improvedmetaboliccontrolusingglucosemonitoringsystemsleadstoimprovementinvibrationperceptionthresholdsintype1diabetespatients
AT elgzyritarg improvedmetaboliccontrolusingglucosemonitoringsystemsleadstoimprovementinvibrationperceptionthresholdsintype1diabetespatients
AT londahlmagnus improvedmetaboliccontrolusingglucosemonitoringsystemsleadstoimprovementinvibrationperceptionthresholdsintype1diabetespatients
AT ekmanlinnea improvedmetaboliccontrolusingglucosemonitoringsystemsleadstoimprovementinvibrationperceptionthresholdsintype1diabetespatients
AT lindholmeero improvedmetaboliccontrolusingglucosemonitoringsystemsleadstoimprovementinvibrationperceptionthresholdsintype1diabetespatients